**Arvee Laboratories India Q3 Results 2025**
On February 12, 2025, Arvee Laboratories India announced its Q3 financial results, revealing a year-on-year revenue growth of 15.71%, totaling ₹8.91 crore. However, the company reported a significant profit decline of 37.5%, with net income at ₹0.15 crore.
In comparison to the previous quarter, the company encountered substantial difficulties, experiencing a revenue drop of 28.89% and a staggering profit decrease of 84.69%. This downward trend raises concerns regarding the viability of their current financial strategies.
Moreover, Selling, General, and Administrative expenses increased by 4.46% quarter-on-quarter and 19.39% year-on-year, which could further strain profitability if not effectively controlled. The operating income also saw a dramatic decline, falling by 94.17% from the previous quarter and 58.82% year-on-year, indicating a significant reduction in operational performance.
The earnings per share (EPS) for Q3 was reported at ₹0.14, reflecting a year-on-year decrease of 36.36, which may signal a potential decline in investor confidence.
In terms of stock performance, Arvee Laboratories India has recorded a return of -2.5% over the past week, -23.37% over the last six months, and -16.4% year-to-date, highlighting a concerning trend for investors.
Currently, the company has a market capitalization of ₹153.29 crore, with a 52-week high of ₹315 and a low of ₹117.05, illustrating the volatility it faces in a competitive market.
**Arvee Laboratories India Financials**
| Period | Q3 (FY25) | Q2 (FY25) | Q-o-Q Growth | Q3 (FY24) | Y-o-Y Growth |
|—————————-|———–|———–|————–|———–|————–|
| Total Revenue | 8.91 | 12.53 | -28.89% | 7.7 | +15.71% |
| Selling/General/Admin Expenses Total | 1.17 | 1.12 | +4.46% | 0.98 | +19.39% |
| Depreciation/Amortization | 0.28 | 0.30 | -6.67% | 0.35 | -20% |
| Total Operating Expense | 8.84 | 11.32 | -21.91% | 7.53 | +17.4% |
| Operating Income | 0.07 | 1.20 | -94.17% | 0.17 | -58.82% |
| Net Income Before Taxes | 0.21 | 1.31 | -83.97% | 0.32 | -34.38% |
| Net Income | 0.15 | 0.98 | -84.69% | 0.24 | -37.5% |
| Diluted Normalized EPS | 0.14 | 0.89 | -84.27% | 0.22 | -36.36% |